Recently
In 1992, the company merged with Applied Biosystems. In 1997 they merged with PerSeptive Biosystems. On July 14, 1999, the new analytical instruments maker PerkinElmer cut 350 jobs, or 12%, in its cost reduction reorganization.[16] In 2006, PerkinElmer sold off the Fluid Sciences division for approximately US$400 million; the aim of the selloff was to increase the strategic focus on its higher-growth health sciences and photonic markets. Following on from the selloff, a number of small businesses were acquired, including Spectral Genomics, Improvision, Evotec-Technologies, Euroscreen, ViaCell, and Avalon Instruments. The brand "Evotec-Technologies" remains the property of Evotec, the former owner company. PerkinElmer had a license to use the brand until the end of year 2007.
PerkinElmer has continued to expand its interest in medicine with the acquisitions of clinical laboratories, In July 2006, it acquired NTD Labs located on Long Island, New York. The laboratory specializes in prenatal screening during the first trimester of pregnancy. In 2007, it purchased ViaCell, Inc. for US$300 million,[17] which included its offices in Boston and cord blood storage facility in Kentucky near Cincinnati. The company was renamed ViaCord. In 2001 Perkin Elmer acquired Packard Bioscience Inc from its majority shareholder, Dick McKernen. This acquisition also came with Agincourt Technologies Inc and consolidated Perkin Elmer's position in laboratory robotics, in particular, liquid handling robots which were to prove essential for the high-throughput sequencing needed for the Human Genome Project.
In March 2008, PerkinElmer purchased Pediatrix Screening (formerly Neo Gen Screening), a laboratory located in Bridgeville, Pennsylvania specializing in screening newborns for various inborn errors of metabolism such as phenylketonuria, hypothyroidism, and sickle-cell disease. It renamed the laboratory PerkinElmer Genetics, Inc.[18]
In May 2011, PerkinElmer announced the signature of an agreement to acquire CambridgeSoft, and the successful acquisition of ArtusLabs.[19]
In September 2011, PerkinElmer bought Caliper Life Sciences for US$600 million.[20]
In December 2014 PerkinElmer acquired Perten Instruments for US$266 million to expand in food testing.[21]
In January 2016, PerkinElmer acquired Swedish firm Vanadis Diagnostics.[22]
In February 2016 PerkinElmer acquired Delta Instruments.[23]
In January 2017, the company announced it would acquire the Indian in vitro diagnostic company, Tulip Diagnostics.[24] In May 2017, the company acquired Euroimmun Medical Laboratory Diagnostics for approximately US$1.3 billion.[25]
In 2018, the company acquired Australian biotech company, RHS Ltd., Chinese manufacturer of analytical instruments, Shanghai Spectrum Instruments Co. Ltd., and France-based company Cisbio Bioassays, which specializes in diagnostics and drug discovery solutions.[26][27][28]
In November 2020, PerkinElmer announced it would acquire Horizon Discovery Group for around US$383 million.[29]
In March 2021, PerkinElmer announced that the company has completed its acquisition of Oxford Immunotec Global PLC (Oxford Immunotec).[30] In May of the same year, the business announced it would purchase Nexcelom Bioscience for $260 million[31][32] and Immunodiagnostic Systems Holdings PLC for $155 million.[33] In June the company announced it would acquire SIRION Biotech, a specialist in viral vector gene delivery methods.[34] In July the business announced it would acquire BioLegend for $5.25 billion.[35]